1. Liu, Y., Meng, X., & Chen, B. (2001). Clinical results of the low intensity of oral anticoagulant therapy for patients with mechanical heart valve prostheses. Chinese Journal of Thoracic and Cardiovascular Surgery, 17, 163–265.
2. Acar, J., Iung, B., Boissel, J. P., Samama, M. M., Michel, P. L., Teppe, J. P., et al. (1996). AREVA: Multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation, 94, 2107–2112.
3. Kayali, M. T., Fetieh, M. W., Abdulsalam, M. A., Memon, F., Moinuddin, M., & Raffa, H. (1998). Thrombotic obstruction of bileaflet mechanical prosthetic heart valves: Early diagnosis and management. The Journal of Cardiovascular Surgery (Torino), 39, 331–335.
4. Kalaria, V. G., Passannante, M. R., Shah, T., Modi, K., & Weisse, A. B. (1998). Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. American Heart Journal, 135, 215–220.
5. Israel, D. H., Sharma, S. K., & Fuster, V. (1994). Antithrombotic therapy in prosthetic heart valve replacement. American Heart Journal, 127, 400–411.